Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Singapore Institute of Advanced Medicine Holdings Ltd. (9G2) Share Price & Analysis

6 Followers

9G2 Stock Chart & Stats

S$0.02S$0.00(0.00%)
At close: 5:00 PM GMT+8
S$0.02S$0.025S$0.03Aug 17Aug 31Sep 14Sep 28Oct 12Oct 23Nov 10
Day’s Range
SGD 0.02 - SGD 0.02
52-Week Range
SGD 0.02 - SGD 0.08
Previous Close
SGD 0.02
Volume
N/A
Average Volume (3M)
219.93K
Market Cap
SGD 36.21M
Enterprise Value
SGD 84.18M
Total Cash (Recent Filing)
SGD 15.18M
Total Debt (Recent Filing)
SGD 61.28M
Price to Earnings (P/E)
―
Beta
-0.43
Next Earnings
Feb 12, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Gross Margin

Gross margin of about 92% in 2024–2026 indicates attractive underlying service economics. If the company can restore revenue and control overhead, this margin structure could provide meaningful operating leverage and a credible pathway toward improved profitability over the next several quarters.

Improved Leverage

Positive equity and materially lower leverage than in 2022–2023 provide some balance-sheet support. Although debt remains above equity and losses constrain self-funding, the deleveraging progress gives the company more resilience than its earlier capital structure.

Narrower Operating Cash Burn

Operating cash outflow narrowed meaningfully in 2026 versus 2024–2025, showing some progress in cash management. This does not eliminate funding pressure, but continued improvement could reduce the rate at which the company consumes resources while it works toward breakeven.

Bears Say

Material Revenue Decline

The roughly 20% revenue decline in 2026 weakens operating leverage and makes fixed costs harder to absorb. A sustained contraction would limit the benefit of the company’s high gross margin, constrain reinvestment capacity, and delay any credible return to profitability.

Severe Persistent Losses

Severely negative margins show that overhead and other costs overwhelm the company’s otherwise strong gross economics. Persistent losses reduce retained resources, keep returns on equity deeply negative, and make a near-term improvement in financial self-sufficiency dependent on major operating changes.

Negative Cash Generation

Continually negative operating and free cash flow means the business is consuming cash rather than funding itself. Even with some improvement in operating burn, ongoing outflows raise funding risk and can restrict the company’s ability to sustain investment or absorb further weakness.

Singapore Institute of Advanced Medicine Holdings Ltd. News

9G2 FAQ

What was Singapore Institute of Advanced Medicine Holdings Ltd.’s price range in the past 12 months?
Singapore Institute of Advanced Medicine Holdings Ltd. lowest share price was S$0.02 and its highest was S$0.08 in the past 12 months.
What is Singapore Institute of Advanced Medicine Holdings Ltd.’s market cap?
Singapore Institute of Advanced Medicine Holdings Ltd.’s market cap is S$36.21M.
When is Singapore Institute of Advanced Medicine Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Singapore Institute of Advanced Medicine Holdings Ltd.’s earnings last quarter?
Singapore Institute of Advanced Medicine Holdings Ltd. released its earnings results on Aug 29, 2026. The company reported -S$0.005 earnings per share for the quarter.
Is Singapore Institute of Advanced Medicine Holdings Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Singapore Institute of Advanced Medicine Holdings Ltd. pay dividends?
Singapore Institute of Advanced Medicine Holdings Ltd. does not currently pay dividends.
What is Singapore Institute of Advanced Medicine Holdings Ltd.’s EPS estimate?
Singapore Institute of Advanced Medicine Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Singapore Institute of Advanced Medicine Holdings Ltd. have?
Singapore Institute of Advanced Medicine Holdings Ltd. has 1,724,092,500 shares outstanding.
What happened to Singapore Institute of Advanced Medicine Holdings Ltd.’s price movement after its last earnings report?
Singapore Institute of Advanced Medicine Holdings Ltd. reported an EPS of -S$0.005 in its last earnings report. Following the earnings report the stock price went down -6.522%.
Which hedge fund is a major shareholder of Singapore Institute of Advanced Medicine Holdings Ltd.?
Currently, no hedge funds are holding shares in SG:9G2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology